[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-rcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":346},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95636,"L'action RCUS bondit de 17,5 % malgré une perte nette de 353 millions de dollars : ce que la juste valeur de 34 $ indique","2026-03-03T19:00:00","2026-03-03T18:53:45","\u003Cp>Voici pourquoi l'action d'Arcus Biosciences a bondi de 17,5 % pour atteindre 24 dollars, les données cliniques et une trésorerie de 981 millions de dollars ayant compensé les pertes croissantes.\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-rcus-stock\">\u003Cstrong>Statistiques clés\u003C\u002Fstrong> pour l'\u003Cstrong>action\u003Cstrong>RCUS\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Variation du cours de l'action \u003Cstrong>RCUS\u003C\u002Fstrong>:\u003C\u002Fstrong> +17.5%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>RCUS\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Cours de l'action au \u003Cstrong>02 mars\u003C\u002Fstrong>:\u003C\u002Fstrong> 24\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Plus haut sur 52 semaines :\u003C\u002Fstrong> 26\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>RCUS\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Objectif de cours : \u003C\u002Fstrong> 34\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">En direct : Découvrez le potentiel de hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">>>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Que s'est-il passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Arcus Biosciences (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">RCUS\u003C\u002Fa>\u003C\u002Fstrong>) a grimpé de 17,5 % cette semaine et se négocie maintenant à 24 $, juste en dessous de son sommet de 52 semaines de 26,40 $. Ce mouvement fait suite à la publication des résultats de la société pour le quatrième trimestre 2025 et à la mise à jour de son portefeuille de produits à la fin du mois de février. Les investisseurs ont également réagi aux nouvelles données cliniques concernant le casdatifan dans le traitement du cancer du rein en phase avancée.\u003C\u002Fp>\n\n\n\n\u003Cp>Selon Reuters, Arcus a enregistré une perte nette de 106 millions de dollars au quatrième trimestre, en hausse de 12,8 % par rapport à l'année précédente. Les dépenses d'exploitation du quatrième trimestre ont totalisé 147 millions de dollars, reflétant l'investissement continu dans son pipeline d'oncologie. Le chiffre d'affaires a baissé au cours du trimestre et les pertes nettes se sont creusées en raison de l'augmentation des coûts de développement.\u003C\u002Fp>\n\n\n\n\u003Cp>Dans le même temps, Arcus a déposé une demande d'offre mixte sur étagère le 26 février. Bien que les dépôts de dossier puissent soulever des problèmes de dilution, l'entreprise maintient une solide position de liquidité. Le total des liquidités et des investissements à court terme s'élevait à 981 millions de dollars à la fin de l'année.\u003C\u002Fp>\n\n\n\n\u003Cp>La société a également annoncé des présentations à la Leerink Global Healthcare Conference et à la Barclays Global Healthcare Conference en mars. Les résultats du premier trimestre 2026 étant attendus le 7 mai, les investisseurs semblent se concentrer sur les progrès du pipeline et la solidité du bilan.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action RCUS (C'est gratuit !) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-market-is-telling-us-about-rcus-stock\">Ce que le marché nous dit à propos de l'action RCUS\u003C\u002Fh2>\n\n\n\n\u003Cp>Le rallye suggère que les investisseurs accordent de la valeur aux actifs cliniques d'Arcus plutôt qu'aux bénéfices à court terme. La société n'est toujours pas rentable, avec une perte nette de 353 millions de dollars au cours des douze derniers mois. Les marges d'exploitation étaient négatives à 156,3 %, ce qui reflète des investissements importants en recherche et développement.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"2560\" height=\"1706\" data-public-id=\"images\u002FTIKR.com_RCUS-Arcus-Biosciences-Inc.-Net-Income-and-Operating-Margins_956379b808\u002FTIKR.com_RCUS-Arcus-Biosciences-Inc.-Net-Income-and-Operating-Margins_956379b808.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2560,h_1706,c_scale\u002Ff_webp,q_auto\u002Fv1772563625\u002Fimages\u002FTIKR.com_RCUS-Arcus-Biosciences-Inc.-Net-Income-and-Operating-Margins_956379b808\u002FTIKR.com_RCUS-Arcus-Biosciences-Inc.-Net-Income-and-Operating-Margins_956379b808.webp?_i=AA\" alt=\"\" class=\"wp-post-95636 wp-image-95637\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772563625\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Le revenu net et les marges d'exploitation de RCUS (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Cependant, Arcus détient 981 millions de dollars de liquidités et d'investissements à court terme contre un passif total de 508 millions de dollars. La dette nette à long terme est négative de 791 millions de dollars, ce qui indique une position de trésorerie nette. Ces liquidités permettent de faire avancer les programmes en phase finale.\u003C\u002Fp>\n\n\n\n\u003Cp>Arcus continue de faire progresser le casdatifan et le domvanalimab dans de multiples indications. Les données récentes de l'étude ARC-20 ont montré une survie médiane sans progression de 15,1 mois pour le casdatifan dans le cancer du rein. Ces résultats ont contribué à modifier le sentiment malgré des pertes trimestrielles de plus en plus importantes.\u003C\u002Fp>\n\n\n\n\u003Cp>Les données du marché reflètent également un intérêt croissant. La capitalisation boursière de la société est d'environ 3 milliards de dollars et le nombre d'actions en circulation s'élève à 125,35 millions. Avec un bêta sur 5 ans de 0,84 et un volume moyen sur 3 mois de 1,57 million d'actions, l'activité boursière s'est accélérée dans les dernières nouvelles.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une entreprise (Gratuit avec TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-arcus-biosciences-inc\">Devriez-vous investir dans Arcus Biosciences, Inc.\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est d'examiner les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cmark style=\"background-color:rgba(0, 0, 0, 0);color:#666666\" class=\"has-inline-color\">données financières de qualité institutionnelle\u003C\u002Fmark>\u003C\u002Fa>\u003C\u002Fstrong> que les analystes professionnels utilisent pour répondre à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>En consultant RCUS, vous verrez des années de données financières historiques, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples d'évaluation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cmark style=\"background-color:rgba(0, 0, 0, 0);color:#666666\" class=\"has-inline-color\">\u003Cstrong>créer une liste de surveillance gratuite pour suivre RCUS\u003C\u002Fstrong>\u003C\u002Fmark>\u003C\u002Fa> ainsi que toutes les autres actions qui vous intéressent. Aucune carte de crédit n'est requise. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003Cstrong>Analyser l'action Arcus Biosciences\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong> \u003Cstrong>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>sur TIKR \u003Cstrong>Free→\u003C\u002Fstrong> \u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Découvrez les actions que les \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n",660,"fr","\u002Fblog\u002Frcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","rcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","images\u002FRCUS-stock\u002FRCUS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772563814\u002Fimages\u002FRCUS-stock\u002FRCUS-stock.png?_i=AA",{"altText":237,"imageCredit":238},"RCUS Stock Jumps 17.5% Despite $353M Net Loss: What $34 Fair Value Signals","Ivan S from Pexels via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Rexielyn Diaz","rexietikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Here’s why Arcus Biosciences stock jumped 17.5% to $24 as clinical data and a $981 million cash position offset widening losses.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","5 minutes",1200,630,[266,281,299,314,329],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"L'action AXT bondit de 22% à 46 dollars : pourquoi les analystes voient toujours une juste valeur de 27 dollars","2026-03-03 18:50:00","Voici pourquoi l'action AXT a bondi de 22,2 % pour atteindre 46 $, les investisseurs regardant au-delà de la faiblesse des marges et vers une croissance projetée de 42 % du chiffre d'affaires.",674,"\u002Fblog\u002Faxt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","axt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","images\u002FAXTI-stock\u002FAXTI-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772562833\u002Fimages\u002FAXTI-stock\u002FAXTI-stock.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":292,"categories":296,"relatedPosts":298},"Johnson & Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03 18:35:00","Johnson & Johnson a bondi d'environ 38 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse régulière jusqu'en 2026. Voici pourquoi l'accélération de la croissance de l'oncologie et l'expansion des marges continuent de soutenir la configuration.",691,"\u002Fblog\u002Fjohnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","johnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772549656\u002Fimages\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva.png?_i=AA",{"altText":291},"Johnson & Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026",{"name":293,"slug":294,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":295},"Nikko Henson","nikkotikr",[],[297],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":300,"date":301,"excerpt":302,"wordCount":303,"uri":304,"slug":305,"cloudinaryAssetId":306,"featuredImageOriginalUrl":307,"featuredImageMetadata":308,"author":309,"categories":311,"relatedPosts":313},"L'action d'Applied Optoelectronics a bondi de 22% cette semaine : Pourquoi les analystes voient une juste valeur de 48","2026-03-03 18:30:00","Voici pourquoi l'action d'Applied Optoelectronics oscille après les résultats et pourquoi les analystes voient encore une hausse jusqu'à 55 $.",718,"\u002Fblog\u002Fapplied-optoelectronics-stock-jumps-22-this-week-why-analysts-see-48-fair-value","applied-optoelectronics-stock-jumps-22-this-week-why-analysts-see-48-fair-value","images\u002FAAOI-stock_956327ccae\u002FAAOI-stock_956327ccae","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772561795\u002Fimages\u002FAAOI-stock_956327ccae\u002FAAOI-stock_956327ccae.png?_i=AA",{"altText":300},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":310},[],[312],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":315,"date":316,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":326,"relatedPosts":328},"IQVIA a progressé de 7 % cette semaine. Voici où l'action pourrait se situer en 2026","2026-03-03 18:05:00","L'action IQVIA a progressé d'environ 7 % cette semaine, et notre analyse suggère que le titre pourrait encore offrir une hausse significative en 2026. Voici pourquoi une croissance commerciale régulière, une demande clinique résiliente et des capacités d'IA en expansion continuent de soutenir la configuration.",735,"\u002Fblog\u002Fiqvia-rose-7-this-week-heres-where-the-stock-could-head-in-2026","iqvia-rose-7-this-week-heres-where-the-stock-could-head-in-2026","images\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772547778\u002Fimages\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223\u002F@SOMKID-THONGDEE-from-Getty-Images-via-Canva-223.png?_i=AA",{"altText":315},{"name":293,"slug":294,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":325},[],[327],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":330,"date":331,"excerpt":332,"wordCount":333,"uri":334,"slug":335,"cloudinaryAssetId":336,"featuredImageOriginalUrl":337,"featuredImageMetadata":338,"author":339,"categories":343,"relatedPosts":345},"Voici pourquoi l'action Edwards Lifesciences pourrait atteindre 150 dollars","2026-03-03 18:00:00","Edwards a mis fin à son enquête antitrust dans l'UE, a lancé SAPIEN M3 et a réaffirmé ses orientations lors de trois conférences d'investisseurs consécutives, mais le développement qui fera réellement remonter le cours de l'action arrivera lorsque la CMS publiera son projet de NCD pour le TAVR en juin.",795,"\u002Fblog\u002Fheres-why-edwards-lifesciences-stock-could-reach-150","heres-why-edwards-lifesciences-stock-could-reach-150","images\u002FFEATURED-IMAGE-MAKER-391\u002FFEATURED-IMAGE-MAKER-391","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772544348\u002Fimages\u002FFEATURED-IMAGE-MAKER-391\u002FFEATURED-IMAGE-MAKER-391.png?_i=AA",{"altText":330},{"name":340,"slug":341,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":342},"Gian Estrada","giantikr",[],[344],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[347,367,382,397,414,429,447,461,476,490],{"id":255,"title":348,"date":349,"excerpt":350,"wordCount":351,"uri":352,"slug":353,"cloudinaryAssetId":354,"featuredImageOriginalUrl":355,"featuredImageMetadata":356,"author":357,"categories":361,"relatedPosts":366},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":348},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":360},"Aditya Raghunath","adityatikr",[],[362],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":368,"date":369,"excerpt":370,"wordCount":371,"uri":372,"slug":373,"cloudinaryAssetId":374,"featuredImageOriginalUrl":375,"featuredImageMetadata":376,"author":377,"categories":379,"relatedPosts":381},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":368},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":378},[],[380],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":383,"date":384,"excerpt":385,"wordCount":386,"uri":387,"slug":388,"cloudinaryAssetId":389,"featuredImageOriginalUrl":390,"featuredImageMetadata":391,"author":392,"categories":394,"relatedPosts":396},"Le financement massif d'OpenAI déclenche la chute des actions d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":383},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":393},[],[395],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":398,"date":399,"excerpt":400,"wordCount":401,"uri":402,"slug":403,"cloudinaryAssetId":404,"featuredImageOriginalUrl":405,"featuredImageMetadata":406,"author":407,"categories":411,"relatedPosts":413},"L'action Chime bondit de 14 % sur la voie de la rentabilité selon les GAAP : voici où l'action pourrait se diriger en 2026","2026-03-01 15:00:00","Les actions de Chime Financial (CHYM) sont en train d'enregistrer une forte hausse après la publication de leurs résultats, suite à la publication d'un rapport sur le quatrième trimestre qui a fait date.",743,"\u002Fblog\u002Fchime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","chime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","images\u002F21-2\u002F21-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322176\u002Fimages\u002F21-2\u002F21-2.png?_i=AA",{"altText":398},{"name":408,"slug":409,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":410},"Wiltone Asuncion","wiltonetikr",[],[412],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":415,"date":416,"excerpt":417,"wordCount":418,"uri":419,"slug":420,"cloudinaryAssetId":421,"featuredImageOriginalUrl":422,"featuredImageMetadata":423,"author":424,"categories":426,"relatedPosts":428},"L'action de Crescent Energy bondit de 7 % grâce à des synergies doublées dans le Permien : Voici où l'action pourrait aller en 2026","2026-03-01 14:50:00","Crescent Energy Company (CRGY) aborde l'année 2026 en tant qu'opérateur multi-bassins à grande échelle, après avoir réalisé des transactions d'une valeur de près de 5 milliards de dollars. ",816,"\u002Fblog\u002Fcrescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","crescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","images\u002F20-2\u002F20-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322164\u002Fimages\u002F20-2\u002F20-2.png?_i=AA",{"altText":415},{"name":408,"slug":409,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":425},[],[427],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":430,"date":431,"excerpt":432,"wordCount":433,"uri":434,"slug":435,"cloudinaryAssetId":436,"featuredImageOriginalUrl":437,"featuredImageMetadata":438,"author":439,"categories":441,"relatedPosts":446},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":430},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":440},[],[442],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":448,"date":369,"excerpt":449,"wordCount":450,"uri":451,"slug":452,"cloudinaryAssetId":453,"featuredImageOriginalUrl":454,"featuredImageMetadata":455,"author":456,"categories":458,"relatedPosts":460},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27% à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":448},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":457},[],[459],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":462,"date":463,"excerpt":464,"wordCount":465,"uri":466,"slug":467,"cloudinaryAssetId":468,"featuredImageOriginalUrl":469,"featuredImageMetadata":470,"author":471,"categories":473,"relatedPosts":475},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":462},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":472},[],[474],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":477,"date":463,"excerpt":478,"wordCount":479,"uri":480,"slug":481,"cloudinaryAssetId":482,"featuredImageOriginalUrl":483,"featuredImageMetadata":484,"author":485,"categories":487,"relatedPosts":489},"En hausse de 19 % au cours des 12 derniers mois, les valeurs financières régionales peuvent-elles encore progresser en 2026 ?","Des bénéfices solides au quatrième trimestre et un taux de rendement des capitaux propres de 18 % placent Regions Financial en position de croissance. Notre modèle prévoit une hausse de 26 % pour atteindre 35 $ d'ici 2028. L'action RF peut-elle tenir ses promesses en 2026 ?",1264,"\u002Fblog\u002Fup-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","up-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","images\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772446487\u002Fimages\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63.png?_i=AA",{"altText":477},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":486},[],[488],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":491,"date":492,"excerpt":493,"wordCount":494,"uri":495,"slug":496,"cloudinaryAssetId":497,"featuredImageOriginalUrl":498,"featuredImageMetadata":499,"author":500,"categories":502,"relatedPosts":504},"En baisse de 65 % par rapport à son plus haut niveau historique, l'action Brown-Forman peut-elle offrir de meilleurs résultats en 2026 ?","2026-03-03 09:45:00","L'action Brown-Forman pourrait atteindre 36 dollars d'ici 2028 grâce au succès du Blackberry de Jack Daniel et à la croissance des marchés émergents, malgré des vents contraires à court terme dans le secteur de la consommation.",1334,"\u002Fblog\u002Fdown-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","down-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","images\u002FBFB-stock\u002FBFB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772433508\u002Fimages\u002FBFB-stock\u002FBFB-stock.png?_i=AA",{"altText":491},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":501},[],[503],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[]]